Treatment With Darolutamide +/- Radiation Therapy for Patients With a Castration Resistant Cancer and Metastases Detected by Functional Imaging

Conditions: Prostatic Cancer, Castration-Resistant Interventions: Drug: Darolutamide 300 mg; Radiation: Stereotactic body radiation therapy; Drug: Androgen deprivation therapy Sponsors: UNICANCER; Bayer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials